Abstract The frailty index (FI), defined by a deficit accumulation approach, has emerged as a promising concept in gerontological research, but applications have been mostly restricted to populations from Canada and the United States aged 65 years or older. Baseline data from the German ESTHER cohort study (N 9,886; age 50-75; mean follow-up 8.7 years) were used to create a FI through a deficit accumulation approach. For estimation of frailty prevalence, we used cut-points for the FI to define three categories (non-frail 0 to B0.20; pre-frail [0.20 to \0.45; frail C0.45). We assessed variation of the FI by age and sex: 10-year survival according to baseline FI was assessed by Kaplan-Meier curves and bivariate and multivariate Cox proportional hazard models. Cubic splines were used to assess sex-specific dose-response associations. Prevalence of frailty was 9.2 and 10.5 % in women and men, respectively. Age-specific prevalence of frailty ranged from 4.6 % in 50-54 year old participants to 17.0 % in 70-75 year old participants. Below 60 years of age, men had a higher FI than women. However, the FI showed a stronger increase with age among women (3.1 % per year) than among men (1.7 % per year) and was higher among women than men in older age groups. Adjusted hazard ratios (95 % confidence intervals) for all-cause mortality were 1.08 (0.84-1.39), 1.32 (1.05-1.66), 1.77 (1.41-2.22), and 2.60 (2.11-3.20) for the 2nd, 3rd, 4th, and 5th quintile of the FI compared to 1st quintile, respectively. There was a strong dose-response relationship between the FI and total mortality among both men and women and both younger (\65 years) and older subjects. We found sex differences in the FI and its increase with age, along with a consistent strong association of the FI with mortality in both sexes, even for age group 50-64.
Introduction
Frailty is an emerging concept describing a multidimensional syndrome in the elderly that is characterized by a loss of physiological reserves, leading to increased vulnerability to a wide range of adverse health outcomes [1] [2] [3] [4] . Frailty as a possible reversible syndrome is of special interest for the healthcare system [5] . In clinical settings, frail patients are at a higher risk for complications, as they have more health-related problems [6] . With growing knowledge on frailty, treatment might be adapted on the needs of frail people to minimize risks for adverse health outcomes and to enable effective rehabilitation.
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In the past decade, several approaches to the definition and measurement of frailty have been proposed [3, 4, [7] [8] [9] [10] [11] [12] . A widely accepted approach was suggested by Fried and colleagues [3] . In this rules-based approach frailty was defined as a clinical syndrome on the basis of the number of the following frailty criteria present: exhaustion, unintentional weight loss, weakness, low gait speed and low physical activity. In another widely used approach, the deficit accumulation approach first proposed by Mitnitski et al. [4] ., frailty is defined as the proportion of a large number of deficits (symptoms, signs, diseases or limitations in activities of daily living) present at the time of investigation, which is commonly denoted as frailty index (FI) [4, 6, 13] . The list of deficits is not fixed, but it has been recommended for statistical reasons that it should include at least 30 deficits [2, 13] . The flexibility in the list of deficits facilitates the retrospective use of this approach in cohort studies which often have measured a large number of albeit often slightly varying deficits.
While the FI has been repeatedly used and found to be highly predictive of adverse health outcomes in studies from various countries, such as Canada, the United States, Mexico, and China [6, [14] [15] [16] [17] , the concept has been applied in only few studies from Europe [18, 19] . Furthermore, studies rarely examined the FI concept in individuals younger than 65 years of age [18, 20, 21] . We aimed to use the accumulation of deficits approach to examine prevalence of frailty at baseline by age and sex, and its association with 10-year mortality in a large cohort study of initially 50-75 year old adults from Germany.
Methods

Study population and data collection
The analyses are based on baseline data and follow-up data of the ESTHER study (ESTHER = Epidemiologische Studie zu Chancen der Verhütung, Früherkennung und optimierten Therapie chronischer Erkrankungen in der älteren Bevölkerung), a large population-based cohort study conducted in Saarland, Germany. A detailed characterization of this ongoing cohort study and the study population has been provided earlier [22, 23] . Briefly, baseline recruitment was done in Saarland, Germany between July 2000 and December 2002 during general health check-up by general practitioners. The only exclusion criterion apart from age (\50 and [75 years) was insufficient knowledge of German language. A standardized questionnaire on sociodemographic, medical, and lifestyle factors was completed by each participant. Finally, the baseline study population included 9,949 participants aged between 50 and 75 years.
History of selected diseases was obtained by the following question: Have one or more of the following diseases ever been diagnosed by a physician? The list of diseases included angina pectoris, primary cardiac insufficiency, stroke, cerebral circulatory disorders, circulatory disorders of the legs, high blood pressure (hypertension), elevated blood lipids (e.g. cholesterol), diabetes mellitus, gout, gall stones, nephrolithiasis, peptic ulcer, Helicobacter pylori infection, cataract, glaucoma, asthma, hay fever, neuro dermatitis, femur fracture, depression, and cancer. Participants were also asked how often they had specific complaints in the last 4 weeks. Information on general health and limitations in activities of daily living was obtained by the SF-12 Ò Health Survey [24] . Body mass index (BMI) was calculated based on self-reported weight and height values, and categorized as proposed by the World Health Organization (underweight \18.50; normal range 18.50-24.99; overweight 25.00-29.99; obese C30.00). Smoking was classified as follows: People who reported smoking of less than 100 cigarettes in their entire life were classified as never smokers. Participants who smoked at least 100 cigarettes during their life were classified as current smokers if they reported to smoke at the time of recruitment and as former smokers otherwise. Vital status was ascertained via local population registries through the end of 2010 and could be ascertained for 9,886 (99.4 %) of participants.
The study was approved by the ethics committees of the medical faculty of the University of Heidelberg and of the medical board of the state of Saarland. Written informed consent was obtained from each participant.
Selection and coding of variables for the FI
The FI counts individuals' deficits in health which can be: symptoms, signs, blood markers, disabilities and diseases. The index is expressed as ratio of the deficits present divided by the total number of deficits considered. The selection of deficits and the construction of the FI followed a standard procedure [13] . At first, we considered 50 potential variables from the baseline questionnaire and applied the following selection criteria: variables must be associated with health status, accumulate with age, do not saturate too early, have more than 1 % prevalence, and should cover a range of health problems and disabilities. In addition, they should not have more than 5 % missing values. We excluded 16 variables, because prevalence was lower than 1 % (femoral neck fracture) or they were not related to age (peptic ulcer, depression, atopic dermatitis, asthma, long-term memory loss, difficulties in personal contact, general feeling: quiet and calm, general feeling: full of energy, general feeling: discouraged, accomplished less work or other regular daily activities than I would like as a result of any emotional problems, did work or other activities less carefully than usual as a result of any emotional problems, back and joint pain, head ache, diarrhoea, and stomach ache).
Finally, 34 variables were included in the FI. They comprised diseases, general health, difficulties in ADL and IADL, and symptoms (Online Resource 1). Each variable was either a binary, 3 level or 5 level variable. We recoded all variables using the convention that 0 indicates the absence of a deficit, and 1 the presence of a deficit. For scaled variables we used additional intermediate values.
Statistical analysis
In order not to exclude participants with missing values, we employed a multiple imputation procedure for all variables included in the FI. Twenty imputed data sets were created with the SAS procedure PROC MI. The maximum number of iterations for imputed values was set to 300. Age, sex, mortality status after 10 years and all selected deficits for construction of the FI (Online Resource 1) were included in the imputation procedure. Scaled variables were dichotomized for each scale level and after multiple imputation the imputed values were rounded to their nearest scale level. All further analyses were performed in the twenty imputed data sets and results of the individual data sets were combined by the SAS procedure PROC MIANALYZE.
Standard descriptive methods were used to describe demographic characteristics of the study sample at baseline, stratified by age groups. Differences between these groups were assessed using ANOVA or Chi square test.
To estimate frailty prevalence at baseline, stratum-specific odds ratios were calculated to identify the cut-points distinguishing frail versus non-frail participants according to their 10-year mortality risk. For this purpose a logistic regression analysis was conducted with 9 pre-defined cutpoints at 0.05, 0.10, 0.15, 0.20, 0.25, 0.30, 0.35, 0.40 and 0.45. A p value of \ 0.05 was used to determine if strata were significantly different from the preceding stratum. Strata determined not to be statistically different from preceding stratum were combined. Finally, we used the following cut-points to define three categories of frailty: non-frail (FI 0 to B0.20), pre-frail (FI [0.20 to \0.45) and frail (FI C0.45).
Weighted regression analyses with age (single years) and sex-specific mean values of the FI as dependent variable, and age and sex as independent variables were used to estimate the increase of the FI with age. Several mathematical functions (linear, quadratic, and log linear) were evaluated to find the best description of the age-FI pattern, overall and stratified by sex, and the best fitting function was selected according to R-squared.
Estimation of 10-year survival was performed using Kaplan-Meier curves for quintiles of the FI, stratified by sex. Differences were tested for statistical significance by the log-rank test. Furthermore, bivariate and multivariate Cox proportional hazard models were employed with the FI as independent variable and sex, age and smoking as covariates. The proportional hazards assumption was evaluated by Schoenfeld residual plots, and by inclusion of time-dependent covariates in univariate and multivariate models. Hazard ratios (HR) with 95 % confidence intervals (CI) were calculated for the overall study sample, and for different subgroups (defined by sex and age). In all models, the FI was included as ordinal variable with the lowest quintile as reference category. We also assessed sex-specific dose-response associations between the FI and total mortality using cubic spline functions with knots at the quintiles of the FI.
An alpha level of 0.05 was used to determine statistical significance. Analyses were performed using SAS, version 9.2 (SAS Institute, Inc., Cary, NC).
Results
Sociodemographic characteristics of the study sample stratified by 5-year age groups are shown in Table 1 . The study sample consisted of 9,886 subjects of whom 54.9 % were females. Mean age was 62.0 years, 50 % of the study population were 60-69 years old. In all age groups, more than two-thirds of the subjects were overweight or obese. Also, the prevalence of overweight slightly increased with increasing age. The FI significantly differed between age groups (p \ 0.001) and increased with age. Prevalence of frailty was 9.7 % overall, and 9.2 and 10.5 % in women and men, respectively. The proportions of participants classified as pre-frail and frail increased with age. They ranged from 32.5 and 4.6 % in 50-54 year old participants to 49.4 and 17.0 % in 70-75 year old participants, respectively. Figure 1 shows sex-specific mean values of the FI by single years of age. Below 60 years of age, men had higher FI values than women, at higher ages FI values were higher in women. Log-linear regression showed the best fit of the increase of the FI with age. The overall mean FI increased by 2.5 % per year, the increase being stronger in women (3.1 %) than in men (1.7 %). Overall, the 99th percentile of deficit accumulation in our study was 0.63. The age-specific 99th percentile increased with age from 0.55 at 50 years to 0.67 at 75 years of age.
Overall 1.121 subjects died within 10 years of the examination, these included 455 (40.6 %) women and 666 (59.4 %) men. The survival probability declined with increasing FI (Fig. 2) . For both women and men, log-rank tests for differences in survival between quintiles of the FI were statistically significant (p \ .0001) and the gaps between the survival curves increased with higher FI values. In all quintiles of the FI men had lower 10-year survival probabilities than women (p \ 0.01 in all strata). Table 2 shows the HRs for 10-year all-cause mortality (crude and adjusted for age, FI and smoking). There was a clear dose-response relationship of the FI with mortality. Subjects in the highest quintile of the FI had a 3.4 fold increased mortality compared to subjects in the lowest quintile. This association was somewhat attenuated but remained strong after control for sex, age and smoking. The association between the FI and mortality appeared to be somewhat stronger among women than among men. However, testing for interaction did not find this difference to be statistically significant.
Further stratification of the analysis by age indicated that the FI predicted mortality equally well among younger (50-64 years) and older participants (65-75 years) ( Table 3) . Dose-response analysis by cubic spline regression suggested a curvilinear association between the FI and mortality, with a steeper increase in mortality at higher FI levels (Fig. 3) .
Discussion
In this study, we followed an established standard procedure to construct and validate a FI based on health-related questions in a large cohort of older adults from Germany, and examined sex-and age specific mean values of the FI as well as prevalence of frailty. Women below 60 years of age had less deficits compared to men of the same age. However, a steeper increase with age was seen among women, and the mean FI was higher among women than among men at older ages. Prevalence of frailty among study participants was 9.2 and 10.5 % in women and men, respectively. Age-specific prevalence of frailty ranged from 4.6 % in 50-54 year old participants to 17.0 % in 70-75 year old participants. We also observed a strong association of the FI with mortality, which was independent of age and smoking. Participants in the highest quintile of the FI had 2-3 times higher mortality than those in the lowest quintile. This association showed little variation by sex and was equally present both below and above 65 years of age. An monotonic increase in prevalence with age is considered as an indicator of construct validity of the FI. In agreement with studies from other countries, a clear agedependency of the FI was observed. However, results slightly varied with respect to the shape of the age-FI association. Whereas most studies observed an accelerating increase of the FI with age, following a quadratic relationship [15, [25] [26] [27] , in our study, like in some previous studies [4, 28, 29] , the association was best described by an exponential function. Despite small differences Table 3 Adjusted hazard ratios for 10-year all-cause mortality among ESTHER participants, stratified by sex and age groups, according to deficit accumulation at baseline between these mathematical relationships there seems to be consistent evidence for an increasingly steep increase of the FI with increasing age. The FI also varies between sexes. Studies from the US, China and Mexico consistently found that women accumulate more deficits than men yet have lower mortality [13, 16, 30, 31] . This pattern suggests that women may compensate health deficits much better than men do. To our knowledge, ours is one of the first studies that assessed prevalence of frailty by an FI approach in a sample including a large number of men and women between 50 and 64 years of age [18, 20, 21] . Intriguingly, we found substantial frailty prevalences even at the younger ages, which furthermore were higher among men than among women. Main reasons for this sex difference might be the higher incidence and prevalence of cardiovascular diseases and of smoking and their adverse consequences among men in this age group. At the same time mortality from these reasons is substantially higher among men than among women, and the higher frailty prevalences among older women than among older men may at least partly be explained by selective survival. Other potential reasons for the stronger increase of frailty prevalence among women than among men may include the more pronounced changes in hormonal status above age 50 and their biological consequences [32] [33] [34] .
The upper limit of deficit accumulation, which was extensively discussed by Rockwood and Mitnitski [35] is also a major characteristic of the FI. In theory, the maximum limit of deficit accumulation is 1.0, but most previous studies reported a 99th percentile limit \0.7 [13, 16, 35] . This upper limit suggests that there is a level of frailty above which mortality might be very high. A complementary explanation to be kept in mind is that people above the observed limit may no longer be able to participate in epidemiological studies due to poor health. It was also stated by Rockwood and Mitnitski [35] that the association of age with the upper limit should have a slope statistically indistinguishable from 0. Even if the upper 99th percentile in our study was on average 0.63, which is Fig. 3 Dose-response association between the frailty index and all-cause mortality derived by cubic splines with knots at the 20th, 40th, 60th, 80th percentiles consistent with findings from other studies, we observed a slight increase of the upper limit with age. The observed relationship of the upper limit with age could be explained by the age range of our study population, in which the maximal upper limit of deficit accumulation may not have been reached yet.
The prevalences of frailty reported in our study are lower than those reported in most previous studies using an accumulation of deficits approach, mainly due to the younger age of the study population [30, [36] [37] [38] [39] . For study populations of similar ages, frailty prevalences were mostly comparable [36] . Obviously, the selection and number of deficits included in the FI as well as the specific cut-points used for definition of frailty affect frailty prevalences. The deficits used to construct the FI in our study were similar to those selected in previous studies [30, [36] [37] [38] [39] , but there was some variation in the coding of deficits and the cut-point used to define frailty. Compared to most previous studies, multi-level categorization rather than dichotomization of deficits was more commonly applied, and a higher cut-point for definition of frailty was used in our study.
In the interpretation of the findings of this large epidemiological study, a number of limitations should be kept in mind. First, all deficits are self-reported and subject to potential reporting bias. The flexibility in calculating the FI with almost all health-related questions from epidemiological surveys is an advantage, but self-reported information may be less accurate than clinical assessments undertaken by trained physicians or nurses. However, selfreported diseases were regularly validated with medical records during the follow-up of the ESTHER cohort, and very high agreement was observed. Second, the ESTHER baseline participants were recruited during a voluntary health check-up and therefore are not a random sample of the whole population, even if they are similar to the total population living in the State of Saarland with respect to major sociodemographic and lifestyle factors [22] . As in any epidemiologic study, we have to assume some underrepresentation of the most ill people though, because they are less likely to be able to participate in a voluntary health check-up compared to healthy people. This may have led to some underestimation of frailty prevalences.
In conclusion, whereas, previous studies mostly assessed only subjects aged 65 years or older, we examined subjects aged 50 years and older, and observed higher mean levels of frailty in men below 60 years of age compared to women. However, frailty prevalence showed a stronger increase with age among women than among men and was higher among women at older ages. Age-specific prevalence of frailty ranged from 4.6 % in 50-54 year old participants to 17.0 % in 70-75 year old participants indicating a non-negligible proportion of frail people even below 60 years of age. We also showed that the FI is highly predictive of mortality even in age group 50-64. Our results support the use of the FI, defined by a deficit accumulation approach, in epidemiological and clinical studies.
